Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 14/20 | 0.61 |
| ▸ | CYP2D6 | P10635 | 11/20 | 0.61 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.51 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29211972 | 0.88 | CYP3A4 (0.55) | CYP3A4CYP2D6ADORA2A | |
| SCHEMBL29211975 | 0.88 | CYP3A4 (0.55) | CYP3A4CYP2D6ADORA2A | |
| SCHEMBL28977844 | 0.88 | CYP3A4 (0.61) | CYP3A4CYP2D6ADORA2A | |
| SCHEMBL29287936 | 0.86 | CYP3A4 (0.55) | CYP3A4CYP2D6ADORA2A | |
| SCHEMBL29287914 | 0.86 | CYP3A4 (0.55) | CYP3A4CYP2D6ADORA2A | |
| SCHEMBL28900522 | 0.85 | CYP3A4 (0.69) | CYP3A4CYP2D6FGFR1 | |
| SCHEMBL28900525 | 0.81 | CYP3A4 (0.59) | CYP3A4CYP2D6ADORA2A | |
| SCHEMBL28753393 | 0.80 | CYP3A4 (0.72) | CYP3A4CYP2D6FGFR1 | |
| Ammonia Solution, Strong SCHEMBL29626854 | 0.80 | CYP3A4 (0.62) | CYP3A4CYP2D6FGFR1 | |
| Ammonia Solution, Strong SCHEMBL29626992 | 0.79 | CYP3A4 (0.61) | CYP3A4CYP2D6FGFR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109485676-B | Novel nucleoside reverse transcriptase inhibitors for antiviral use | 深圳市塔吉瑞生物医药有限公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-108350008-B | Novel acyclic nucleoside analogue and pharmaceutical composition thereof | 深圳市塔吉瑞生物医药有限公司 | 2020-11-03 | — | — | CN | disclosed |